![](/img/cover-not-exists.png)
P-139Monitoring of erlotinib plasma concentrations after long time administration of 100 mg in advanced pancreatic cancer patients
Sahmanovic, A., Buchner, P., Lichtneckert, M., Dittrich, C., Farkouh, A., Gruber, A., Baroian, N., Kitzmueller, M., Czejka, M.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.133
Date:
June, 2016
File:
PDF, 191 KB
2016